HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jindong Xie Selected Research

Transforming Growth Factor beta (TGF-beta)

12/2022The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jindong Xie Research Topics

Disease

22Neoplasms (Cancer)
04/2024 - 01/2022
10Neoplasm Metastasis (Metastasis)
04/2024 - 01/2022
10Breast Neoplasms (Breast Cancer)
02/2024 - 01/2022
7Triple Negative Breast Neoplasms
03/2024 - 01/2021
2Carcinogenesis
01/2022 - 01/2022
1Epilepsy (Aura)
01/2024
1Liver Neoplasms (Liver Cancer)
01/2024
1Pathologic Processes
01/2024
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024
1Genomic Instability
12/2023
1Communicable Diseases (Infectious Diseases)
12/2023
1Lung Neoplasms (Lung Cancer)
11/2023
1Bone Diseases (Bone Disease)
11/2023
1Brain Neoplasms (Brain Tumor)
01/2023
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023
1Disease Progression
01/2022
1Parkinson Disease (Parkinson's Disease)
02/2012

Drug/Important Bio-Agent (IBA)

6RNA (Ribonucleic Acid)IBA
02/2024 - 01/2022
5Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2021
5Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2022
2Circular RNAIBA
04/2024 - 01/2024
2Transcription Factors (Transcription Factor)IBA
04/2024 - 12/2022
2Immune Checkpoint InhibitorsIBA
04/2024 - 01/2022
2Docetaxel (Taxotere)FDA Link
02/2024 - 11/2022
2BiglycanIBA
01/2023 - 01/2022
1Apolipoproteins E (ApoE)IBA
04/2024
1Glycogen Synthase (Synthase I)IBA
03/2024
1Mechanistic Target of Rapamycin Complex 1IBA
02/2024
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
02/2024
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2024
1Carrier Proteins (Binding Protein)IBA
01/2024
1Competitive Endogenous RNAIBA
01/2024
1Phosphopyruvate Hydratase (Enolase)IBA
01/2024
1Messenger RNA (mRNA)IBA
01/2024
1MicroRNAs (MicroRNA)IBA
01/2024
1Piwi-Interacting RNAIBA
12/2023
1Histone ChaperonesIBA
12/2023
1Aurora Kinase AIBA
12/2023
1VaccinesIBA
12/2023
1A 7 (A-7)IBA
11/2023
1Diphosphates (Pyrophosphates)IBA
11/2023
1Technetium Tc 99m MedronateIBA
11/2023
1CateninsIBA
01/2023
1Immune Checkpoint ProteinsIBA
01/2023
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
01/2023
1Transforming Growth Factor beta (TGF-beta)IBA
12/2022
1beta CateninIBA
12/2022
1palbociclibIBA
11/2022
1Phenobarbital (Luminal)FDA Link
11/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2022
1Indicators and Reagents (Reagents)IBA
11/2022
1Therapeutic UsesIBA
01/2022
1LipidsIBA
01/2022
1Potassium Channels (Potassium Channel)IBA
01/2022
1CytokinesIBA
01/2022
1pyrimidineIBA
01/2022
1N-methyladenosineIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Estrogen ReceptorsIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
01/2021
1epimedii flavoneIBA
02/2012
1Neuroprotective AgentsIBA
02/2012
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2012
1Plant Preparations (Preparation, Plant)IBA
02/2012
1Selegiline (E250)FDA LinkGeneric
02/2012
1Nerve Growth Factors (Neurotrophins)IBA
02/2012
1Caspase 3 (Caspase-3)IBA
02/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2012

Therapy/Procedure

14Immunotherapy
04/2024 - 01/2022
10Therapeutics
04/2024 - 01/2022
1Adjuvant Chemotherapy
11/2022
1Drug Therapy (Chemotherapy)
11/2022
1Intraperitoneal Injections
02/2012